ArticleFrontiers in surgery2026
Case Series: Single-port subxiphoid robotic excision of ectopic mediastinal parathyroid adenomas.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ectopic mediastinal parathyroid adenomas are a rare cause of persistent primary hyperparathyroidism and present operative challenges due to proximity to major mediastinal structures. Robotic trans-subxiphoid resection using multi-port platforms has been described; however, experience with a true uniportal single-port robotic approach remains limited. Methods: We report a case series of two patients with biochemically confirmed primary hyperparathyroidism and imaging-localized anterior mediastinal parathyroid adenomas who underwent excision using a single-port subxiphoid robotic technique with the da Vinci SP system. Operative variables, intraoperative parathyroid hormone (PTH) response, perioperative outcomes, and pathology were analyzed. Results: Single-port subxiphoid robotic excision was completed successfully in 100% (2/2) of cases with no conversions and no intraoperative complications. Mean operative time was 150 min (170 and 130 min), and estimated blood loss was <50 mL in both cases. Critical structures, including the innominate vein and bilateral phrenic nerves, were clearly visualized and preserved. Intraoperative PTH levels decreased by >80% at 10 min post-excision in both patients, meeting Miami criteria. PTH decreased from 172 pg/mL to 22 pg/mL in one patient and from 296 pg/mL to 99 pg/mL, with subsequent normalization, in the other. Both patients were discharged on postoperative day one with normalization of ionized calcium at 1-week follow-up. Final pathology confirmed parathyroid adenoma in both cases. Conclusions: This series demonstrates the safety and feasibility of a true uniportal single-port subxiphoid robotic approach for ectopic mediastinal parathyroid adenomas and highlights its potential as a highly minimally invasive alternative for selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.